CMC strategy Archives

24 Feb

Articles
No Comments

Who Is Arc Nouvel? A Conversation with Dr. Gavin Liu on Cell Therapy CMC Strategy and GMP Manufacturing

Arc Nouvel works with biotechnology and pharmaceutical companies at inflection points, pre-IND preparation, early clinical transitions, manufacturing evolution, and regulatory engagement. At these moments, scientific promise alone is not enough. What determines whether a therapy advances efficiently or stalls under...

27 Jan

Articles
No Comments

Cancer Vaccine CMC Strategy: FDA Expectations for Manufacturing and Regulatory Readiness

Cancer vaccine manufacturing companies engaging the FDA must demonstrate a clear, phase-appropriate CMC strategy that supports both clinical development and eventual licensure. FDA expectations for cancer vaccines, particularly personalized and combination products, extend beyond early IND readiness into manufacturing controls,...

Announcement (1)
Articles (12)

CMC strategy

Who Is Arc Nouvel? A Conversation with Dr. Gavin Liu on Cell Therapy CMC Strategy and GMP Manufacturing

Cancer Vaccine CMC Strategy: FDA Expectations for Manufacturing and Regulatory Readiness

Contact us Now

Menu

Contact Us

Follow Us